OrganoClick AB (publ) publishes information memorandum in connection with the company's rights issue of shares
OrganoClick AB (publ) ("OrganoClick" or the "Company") has prepared and today publishes an information memorandum for the upcoming issue of shares with preferential rights for existing shareholders (the "Rights Issue"), which the Company's Board of Directors proposed on July 17, 2025 and which the Company's Extraordinary General Meeting resolved on August 5, 2025. In order to provide a more comprehensive basis for decision-making regarding the upcoming rights issue, the Company has prepared an information memorandum containing background, motives and complete terms and conditions and instructions for the rights issue. The information memorandum is attached to this press release and is available on the Company's website, (https://organoclick.com/about/corporate-governance/general-meeting/)
THIS PRESS RELEASE MAY NOT BE RELEASED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE THE ANNOUNCEMENT, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE ADDITIONAL REGISTRATION MEASURES.
SUMMARY OF THE OFFER
Rights issue
The issue comprises a maximum of 11,543,290 shares, and can generate up to SEK 20.3 million for the Company before issue costs, which are estimated at approximately 2 percent (SEK 0.4 million) of the issue amount.
Preferential Rights and Record Date
The last day for trading in the shares including the right to participate in the New Issue is August 4, 2025 and the first day for trading in the shares excluding the right to participate in the New Issue is August 5, 2025. The record date is August 6, 2025.
Shareholders in the Company receive two (2) subscription rights for one (1) share held. Seventeen (17) subscription rights are required to subscribe for one (1) new share.
Subscription period
August 8 - August 22, 2025.
Subscription price
SEK 1.76/share. No brokerage fee is charged.
Number of shares before the New Issue
98,117,967 shares.
Trading in subscription rights
Trading in subscription rights will take place on First North during the period 8-19 August 2025.
Information about the share
Trading venue: Nasdaq First North Growth Market
Short name: ORGC
ISIN code: SE0006510335
Subscription commitments
In connection with the Offer, OrganoClick has received subscription and guarantee commitments corresponding to 100% of the Rights Issue from the Company’s three largest shareholders pro-rata in accordance with the table in the information memorandum. No remuneration is paid for these subscription commitments.
Advisors
Advokatfirman Delphi is acting as legal advisor to the Company in connection with the Rights Issue. Eminova Fondkommission has been engaged as issuing agent in connection with the Rights Issue.
For more information, terms and conditions and instructions, see attached information memorandum.
.........................................................................................
For more information, please contact:
Mårten Hellberg, CEO
0707 - 16 48 90, marten.hellberg@organoclick.com
……………………………………………………………………………………………………………………………………………………………….
About OrganoClick
OrganoClick is a Swedish green chemical company, founded in 2006 replacing hidden plastic and harmful chemicals in fiber-based materials with green chemical solutions based on fossil-free raw materials. Based on the company's patented "OrganoClick" technologies, which are inspired by nature's chemistry, OrganoClick develops, produces and markets a range of products with the aim of enabling a green transition. For example, the biobased binder OC-BioBinder for the nonwoven and paper industry, the biodegradable textile impregnation OrganoTex® for consumers and the textile industry, the biocidal-free wood protection technology OrganoWood® for wood treatment companies and the construction industry, as well as eco-labelled maintenance products for home owners under the BIOkleen brand. OrganoClick was founded as a spin-off from Stockholm University and the Swedish Agricultural University and has received several awards for its green innovations, including being named a "Climate Solver" by the World Wide Fund for Nature - WWF. The company is listed on the Nasdaq First North Growth Market and has its headquarters, production and R&D in Täby, north of Stockholm. OrganoClick's Certified Adviser on the Nasdaq First North Growth Market is Mangold Fondkommission AB, tel: +46 (0)8 503 01 551, email: ca@mangold.se.
https://news.cision.com/organoclick-ab/r/organoclick-ab--publ--publishes-information-memorandum-in-connection-with-the-company-s-rights-issue%2Cc4215252
Release
Information memorandum Rights Issue OrganoClick AB Aug 2025
